|
|
|
| Abstract Submission guidelines |
| （ |
The 67th Annual Meeting of the Japanese Society of Pediatric Hematology/Oncology） |
|
|
1. |
Abstract Submission |
|
| |
| 10:00 April 8 (Tue), 2025 |
- |
12:00 May 27 (Tue) , 2025 |
| （Japan Standard Time) |
|
|
|
|
|
2. |
Application for Abstract
(Paper Presentation/Poster Presentation) |
|
| |
Select the style of presentation, either Paper presentation or Poster presentation.
Select an appropriate category from the following list. |
|
| |
| 001 |
ALL |
019 |
Miscellaneous Solid Tumors |
| 002 |
AML |
020 |
Diagnostic Imaging |
| 003 |
Lymphoma |
021 |
Hematopoietic Cell Transplantation |
| 004 |
Myeloproliferative Disorder |
022 |
Surgery |
| 005 |
MDS/JMML |
023 |
Radiotherapy |
| 006 |
Aplastic Anemia |
024 |
Novel Approach |
| 007 |
Thrombosis and Hemostasis |
025 |
Supportive Care |
| 008 |
Platelet |
026 |
Late Effect |
| 009 |
HLH/LCH |
027 |
Palliative Care |
| 010 |
Miscellaneous Hematological Disorders |
028 |
Support for children and their family |
| 011 |
Brain Tumor |
029 |
Epidemiology/Biostatistics |
| 012 |
Neuroblastoma |
030 |
International Cooperation |
| 013 |
Renal Tumor |
031 |
Immune Disorder |
| 014 |
Liver Tumor |
032 |
Pathology |
| 015 |
Ewing Sarcoma |
033 |
Basic Research for Solid Tumors |
| 016 |
Rhabdomyosarcoma |
034 |
Vascular Malformation |
| 017 |
Osteosarcoma |
035 |
Miscellaneous |
| 018 |
Germ Cell Tumor |
|
|
|
|
|
|
3. |
Submission Guidelines |
|
| |
| Language |
English |
| Abstract Title |
20 words including spaces |
| Abstract Body N |
No longer than 350 words |
| No. of authors |
Maximum 15 persons
(including first author and co-authors) |
|
|
| |
| • |
Online registration is required before the congress date. |
|
| • |
All the submitted abstracts will be equally evaluated by peer-reviewed by the program committee. Please note that the decision on abstract acceptance/rejection is left to the sole discretion of the Congress President. |
|
| • |
Notification of acceptance/rejection of your abstract will be sent to the registered e-mail by the evening on 31 on August, 2025. |
|
| • |
All the accepted English abstracts will be published in Pediatric Blood & Cancer. |
|
|
|
|
|
4. |
Conflict of Interest (COI) |
|
| |
| • |
The presenting author is required to report applicable COI of not only the presenting author, but also all co-authors. Please refer to the JSPHO website for details. |
|
| |
|
|
| • |
The first author who is required to declare a conflict of interest should register COI disclosure at the time of abstract submission. |
|
| • |
Notification of acceptance/rejection of your abstract will be sent to the registered e-mail by the evening on 31 August, 2024. 30 September, 2024. |
|
| • |
For Paper Presentation, all speakers must disclose their COI status of the past 3 years on the second slide of your presentation slide. |
|
|
| |
| SAMPLE (For Paper Presentation) |
|
 |
|
 |
|
|
|
|
| |
| • |
For Poster Presentation, all presenters must disclose their COI status of the past 3 years at the end of the poster presentation. |
|
| SAMPLE (For Poster Presentation) |
|
 |
|
|
|
|
|
5. |
Abstract Submission |
|
| |
| • |
All abstracts should be submitted by email. (Email: jspho2025-ab@congre.co.jp) |
|
| • |
Title of the Email should include “Abstract Submission_(Your Name)”. |
|
| • |
Please download and attach the following files in your email. |
|
|
| |
|
|
|
|
|
6. |
Inquiries |
|
| |
Congress Secretariat of
The 67th Annual Meeting of The Japanese Society of Pediatric Hematology/Oncology
The 23rd Annual Meeting of the Japanese Society of Pediatric Oncology Nursing
The 30th Open Symposium of the Childrenʼs Cancer Association of Japan |
|
| |
c/o Congrès Inc.
1-9-17 Tenjin, Chuo-ku, Fukuoka 810-0001 Japan
TEL: +81-92-718-3531
E-mail:jspho2025-ab@congre.co.jp |
|
